GYROSCOPE THERAPEUTICS LIMITED (10131257) is a private limited company registered in SE1 2AF, incorporated in 2016. The company operates in the research and experimental development on biotechnology sector. Our database holds 22 signals from 12 official sources covering this company's filings, appointments, and regulatory records. The company's risk assessment is rated "critical" with a score of 12/100, indicating areas that may warrant further investigation. The company has 1 outstanding mortgage charge registered with Companies House. Note: the company's accounts appear to be overdue.
GYROSCOPE THERAPEUTICS LIMITED is an active private limited company incorporated in 2016, located in London, engaged in research and experimental development on biotechnology, with four active officers and one active charge.
Standard data coverage across 12 sources. Risk score of 12 — significant risk signals detected.
GYROSCOPE THERAPEUTICS LIMITED is 1 of 1 research and experimental development on biotechnology companies in SE1 2AF, out of 4,024 active companies in this sector nationally (4,909 including dissolved).
The 3 directors of GYROSCOPE THERAPEUTICS LIMITED are connected to 7 other companies.
None of these connected companies have been dissolved.
GYROSCOPE THERAPEUTICS LIMITED is listed as the proprietor of 2 properties in the HM Land Registry.
Properties are located in Greater London.
GYROSCOPE THERAPEUTICS LIMITED has received 1 Innovate UK grant.
This company profile is built from 9 official data sources: Ch Officers, Companies House, Gateway to Research, HM Land Registry, HMRC Trade Info, ICO, Innovate UK, Modern Slavery Registry, Uk Trade Info.
GYROSCOPE THERAPEUTICS LIMITED is an active private limited company incorporated in 2016, located in London, engaged in research and experimental development on biotechnology, with four active officers and one active charge..
Current directors include MR CHINMAY UMESH BHATT, MR JOHAN MIKAEL OLOF KAHLSTROEM, MR SANDEEP GUPTA and 1 more.
GYROSCOPE THERAPEUTICS LIMITED is registered in SE1 2AF, United Kingdom.
GYROSCOPE THERAPEUTICS LIMITED operates under SIC code 72110 — Research and experimental development on biotechnology.
GYROSCOPE THERAPEUTICS LIMITED has a risk score of 12 out of 100, classified as "Critical". This score is calculated from 22 data signals across 12 government sources.
The next accounts for GYROSCOPE THERAPEUTICS LIMITED are due on 30 Sept 2026 — this filing is currently overdue.
Yes, GYROSCOPE THERAPEUTICS LIMITED is listed as the proprietor of 2 properties in the HM Land Registry, located in Greater London.
The dissolution rate for the research and experimental development on biotechnology sector in the UK is 12.2%. The average company age in this sector is 7.2 years.
GYROSCOPE THERAPEUTICS LIMITED is currently listed as "Active" on Companies House, indicating it is still a registered company. An "Active" status means the company has not been dissolved, struck off, or entered into liquidation.
GYROSCOPE THERAPEUTICS LIMITED is registered as a Private Limited Company, which is a company limited by shares whose shares are not offered to the general public. It is the most common type of UK company, offering limited liability to its shareholders.
GYROSCOPE THERAPEUTICS LIMITED was incorporated on 18 Apr 2016, making it 10 years old. The company remains active and in good standing.
GYROSCOPE THERAPEUTICS LIMITED is classified under SIC code 72110 (Research and experimental development on biotechnology). The Standard Industrial Classification system is used by the UK government to categorise businesses by their primary economic activity.
We track 22 data signals from 12 official government sources for GYROSCOPE THERAPEUTICS LIMITED.